Disruptive innovation at the interfaces of the drug industry
Journal: Indian Drugs (Vol.56, No. 08)Publication Date: 2019-08-28
Authors : V. Premnath Head NCL Innovations; Director Venture Center CSIR-National Chemical Laboratory Pune;
Page : 5-6
Keywords : ;
Abstract
Dr V. Premnath is currently the Head, NCL Innovations – the group within National Chemical Laboratory (NCL) charged with the responsibility of championing the cause of technology innovation within NCL. Dr Premnath is also the Director of the Venture Center – a technology business incubator on the NCL campus. Dr Premnath is also a Scientist, Polymer Science & Engineering Division at NCL with an interest in technology development for medical products.
Dr. V. Premnath holds a B.Tech. from the Indian Institute of Technology - Bombay and a Ph.D. from the Massachusetts Institute of Technology, USA. He has also been a Chevening Technology Enterprise Fellow with the Centre for Scientific Enterprises, London Business School and Cambridge University, UK. Dr Premnath's experience with medical products development is focused on polymeric implants and has resulted in two families of commercial products and two startups.
Other Latest Articles
- P-Available Enhancement Mechanism through Combinations of Organic Matters and Incubation Period in Psammentic Paleudults Soil
- Effect of Cowpea Seeding Density on Growth Parameters and Grain Yield of Maize in a real Crop Situation in Northern Côte d'Ivoire
- Utilization of Sludge Waste as Fertilizer for Chili Plants: Observed from Technical, Economical Aspects and Farmers' Perceptions
- Efficacy of Different Glyphosate rates of Application on Weed Infestation in Citrus Orchards
- Breeding and testing single-cross maize hybrid QT55 in provinces in the North, South Central and Central Highlands of Vietnam
Last modified: 2019-09-04 14:04:32